Abrupt disease onset and severe metabolic disorders are main characteristics of fulminant type 1 diabetes. Diffusionweighted magnetic resonance imaging (DWI) is an imaging technique that reflects restricted diffusion in organs and can detect mononuclear cell infiltration into the pancreas at the onset of the disease. Fourteen patients with fulminant type 1 diabetes who underwent abdominal magnetic resonance imaging were recruited for the measurement of apparent diffusion coefficient (ADC) values of the pancreas that were compared with those of 21 non-diabetic controls. The ADC values of all parts of the pancreas were significantly lower in fulminant type 1 diabetes than in controls (head, 1.424 ± 0.382 × 10 −3 vs.
Introduction
Type 1 diabetes mellitus is characterized by an absolute insulin deficiency derived from beta-cell destruction [1, 2] . Fulminant type 1 diabetes accounts for 20% of acute onset type 1 diabetes in Japan and recent reports have revealed that this subtype is a major type in other East Asian countries such as Korea and China [3, 4] . This disease is life threatening and is characterized by an extremely abrupt onset with ketoacidosis, and, therefore, needs to be diagnosed and treated as soon as possible. Other characteristics of fulminant type 1 diabetes include high plasma glucose levels accompanied with almost normal glycated hemoglobin (HbA1c) levels, absence of islet-related autoantibodies in general, elevated levels of exocrine pancreatic enzymes (up to 98% of patients with fulminant type 1 diabetes), and very low levels of C-peptide [5] [6] [7] [8] . However, each of these factors is not specific to fulminant type 1 diabetes. To diagnose fulminant type 1 diabetes more accurately, more specific biochemical, immunological or other markers are recommended.
Diffusion-weighted magnetic resonance imaging (DWI) is an advanced imaging technique that reflects the random movement of water molecules within extracellular spaces 
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and between intracellular and extracellular spaces. Apparent diffusion coefficient (ADC) values, which can be calculated from DWI data, are usually used for the quantitative assessment of water mobility in various organs. DWI was established primarily for the diagnosis of acute stroke and brain tumors, which impair water mobility [9, 10] . Following recent technical advances, DWI has also been used to detect various disorders of abdominal organs, such as liver fibrosis and Crohn's disease [11, 12] , and there are reports that pancreatic inflammatory diseases such as acute pancreatitis (AP), chronic pancreatitis (CP), and autoimmune pancreatitis (AIP) can be detected by DWI as high intensity areas or as decreased ADC values indicating a restricted diffusion in specific organs resulting from fibrosis, and the infiltration of inflammatory cells [13] [14] [15] [16] [17] [18] [19] . If mononuclear cell infiltration into the pancreas at the onset of fulminant type 1 diabetes can be detected by DWI, it will be a useful technique for the diagnosis of disease. In the present study, we compared ADC values of the pancreas between fulminant type 1 diabetes and non-diabetic control subjects, and then examined its potential association to several clinical parameters related to diabetes.
Subjects and methods

Subjects
We retrospectively reviewed the records of patient with fulminant type 1 diabetes registered to the committee of the Japan Diabetes Society from 2001 to 2013. They were diagnosed in accordance with the following inclusion criteria proposed by the Committee of the Japan Diabetes Society: (1) presence of ketosis or ketoacidosis within a week after the onset of hyperglycemic symptoms; (2) plasma glucose level ≥ 16.0 mmol/l (288 mg/dl) and HbA1c level < 8.7%* at first visit (*this value is not applicable for patients with previously diagnosed glucose intolerance); (3) urinary C-peptide excretion < 10 μg/day or fasting serum C-peptide level < 0.3 ng/ml (0.10 nmol/l) and peak serum C-peptide level < 0.5 ng/ml (0.17 nmol/l) after intravenous glucagon (1 mg) injection or a meal load soon after disease onset [20] . Fifty patients underwent abdominal MRI within about 1 month after disease onset (4-40 days) for the purpose of examining the causes of elevated serum levels of exocrine pancreatic enzymes or abdominal symptoms. There were two patients difficult to diagnose with fulminant type 1 diabetes. One patient with type 2 diabetes showed high HbA1c level at the disease onset (8.9%). Another patient lacked definite elevation in exocrine pancreatic enzymes: serum amylase, elastase-1, and lipase levels were 0.25, 0.42, and 0.61 times higher than the upper limit of the normal range, respectively.
Previous studies reported that the ADC values of gray and white matter measured from MRI data are variable among different MRI vendors, although the variability in ADC values from three MRI vendors (Siemens Medical Solutions, Erlangen, Germany; GE Healthcare, Milwaukee, WI, USA; Philips Healthcare, Best, the Netherlands) was relatively small [21] . It was also reported that there was no significant difference among ADC values of the pancreas using 1.5-T MR systems from these three vendors [22] . There were 14 patients enrolled whose MRI data were obtained using these three vendors and that was clear enough to examine (MRI systems are: MAGNETOM avanto and MAGNETOM symphony from Siemens Medical Solutions; SIGNA EXCITE, GENESIS-SIGNA, and SIGNA HDxt from GE Healthcare; ACHIEVA from Philips Healthcare). Especially, MRI data of four patients were from exactly the same MRI systems as non-diabetic control subjects (MAGNETOM Avanto 1.5 T from Siemens Medical Solutions). These 14 patients comprised the study subjects. MRI was performed at 13.7 ± 8.2 days (mean ± SD) after disease onset.
For the non-diabetic control subjects, we enrolled 21 patients from Ikeda Hospital for whom abdominal MRI was performed to examine abdominal diseases except of the pancreas (MRI system is MAGNETOM avanto from Siemens Medical Solutions). The clinical characteristics of the subjects are shown in Table 1 . 
MR imaging protocols
For the 21 non-diabetic control subjects, MR imaging examinations were performed using the Magnetom Avanto 
Assessment
The ADC values were measured by drawing a circular region of interest (ROI) within the pancreas from ADC maps using PACSPLUS Clinic Viewer (PACSPLUS, Tokyo, Japan). Three ROIs were placed in each of the head, body, and tail of the pancreas. The mean of these three ADC values in each part of the pancreas was calculated. Mean ADC values were determined from mean values ADC values in the head, body, and tail of pancreas in each patient.
Statistical analysis
Data are presented as the mean ± standard deviation (SD). The Mann-Whitney U test was used for comparison of ADC values between patients with fulminant type 1 diabetes and non-diabetic control subjects. Receiver operating characteristic (ROC) curves were used to determine the appropriate cut-off values for ADC values to diagnose fulminant type 1 diabetes. The best cut-off values were determined by the point on the curve closest to the (0, 1) point. The correlation between ADC values and clinical data was evaluated by Spearman's rank correlation coefficient. All statistical analyses were performed with StatView Ver. 5.0 software (SAS Institute Inc., Cary, NC), and statistical significance was defined as p < 0.05.
Results
Comparison of ADC values of pancreas between patients with fulminant type 1 diabetes and non-diabetic control subjects
The DWI images and ADC map of a representative case of fulminant type 1 diabetes are shown in Fig. 1 . We measured ADC values of the pancreas head, body, and tail in the two groups. Among 14 patients with fulminant type 1 diabetes, we first examined four patients using the same MRI systems and vendors as the control subjects (Magnetom Avanto 1.5 T, Siemens Medical Solutions). The ADC values of patients with fulminant type 1 diabetes were significantly lower than those of non-diabetic control subjects in all parts of the pancreas (head, 1. 
Association between ADC values and plasma glucose and arterial pH
Regarding the fulminant type 1 diabetes group, we examined the association between ADC values and clinical parameters including the number of days taken to perform MRI since the disease onset, age, body mass index, plasma glucose level, HbA1c level, serum amylase, lipase, and elastase-1 levels, as well as arterial pH level at disease onset. The ADC values in all parts of the pancreas and plasma glucose levels at disease onset were significantly correlated (head, r s = − 0.622, p < 0.05; body, r s = − 0.565, p < 0.05; tail, r s = − 0.622, p < 0.05; mean, r s = − 0.640, p < 0.05). The ADC values of pancreas head, body, mean and arterial pH levels were also significantly correlated except for tail (head, r s = 0.635, p < 0.05; body, r s = 0.560, p < 0.05; tail, r s = 0.424, p = 0.126; mean, r s = 0.569, p < 0.05) (Fig. 3) . There was no relationship between the ADC values and the other parameters (number of days taken to perform MRI since the disease onset, age, body mass index, HbA1c level, serum amylase, lipase, and elastase-1 levels; data not shown).
Chronological changes in the ADC values
Among 14 patients with fulminant type 1 diabetes, the chronological changes in the ADC values were able to be observed up to 200 days in 3 patients (Fig. 4) . ADC values tended to increase with a lapse in time.
Discussion
We have reported significant differences in ADC values of the pancreas between patients with fulminant type 1 diabetes and non-diabetic control subjects in the present study. MRI may provide an additional tool of efficient diagnosing the disease which requires immediate treatment because of its severity. Massive cellular infiltration consisting of T cells and macrophages was detected in both endocrine and exocrine pancreas a few days after the onset of fulminant type 1 diabetes [23, 24] . It might cause the low ADC values through the restriction of water diffusion.
We aimed to clarify the importance of DWI in this study because the existing indices, including plasma glucose and HbA1c, are not satisfactorily specific to diagnose fulminant type 1 diabetes [7] . The present study revealed that ADC values could diagnose fulminant type 1 diabetes with moderate accuracy. All ADC values of the pancreatic head, body and tail showed high sensitivity and specificity, and the mean ADC values were the most efficient for diagnosing fulminant type 1 diabetes. The best cut-off value indicated that the sensitivity was 86% and the specificity was 71% using DWI. ADC values were also efficient for two marginal patients with fulminant type 1 diabetes; one with lacked definite elevation in exocrine pancreatic enzymes and another with higher HbA1c levels than the criterion because of previously diagnosed glucose intolerance.
We demonstrated that ADC values of the pancreas were negatively correlated with plasma glucose at disease onset and positively with arterial pH. It is known that massive cell infiltration into the pancreas leads to beta-cell destruction followed by absolute insulin deficiency in fulminant type 1 diabetes. Absolute insulin deficiency results in hyperglycemia, acceleration of lipolysis in the adipose tissue, and finally in the increment of ketogenesis in the liver. This might indicate that low ADC values reflect severe metabolic disorders. Recent studies have shown that DWI can be used to detect tumor lesions as well as the assessment of severity of other diseases. ADC values have been reported as having an association with the activity index of Crohn's disease [12] , degree of pancreatic fibrosis [25] , and pathology scores of chronic kidney disease [26] . Although patients with fulminant type 1 diabetes were significantly younger than non-diabetic control subjects in this study, there was no correlation between pancreatic ADC values and age in a previous report [27] .
In the present study, serum amylase levels did not correlate with ADC values. Thus, the value might parallel the degree of cellular infiltration, but not exocrine disorder as shown by increased amylase levels in fulminant type 1 diabetes in this study.
We confirmed that the pancreatic ADC values of three patients with fulminant type 1 diabetes increased in a course of several months after the first MRI image at the disease onset. There are several reports showing that ADC values changed by treatment over a few months. Taniguchi et al. showed in patients with autoimmune pancreatitis that ADC values of the pancreas were lower than [16] . In addition, ADC values were also shown to have increased after therapy for cervical cancer or lymphoma [28, 29] . This is a retrospective study that has a limitation. The number of patients with fulminant type 1 diabetes in whom abdominal MRI test was performed at the onset of disease is limited. To minimize the variability of ADC values, we selected 3 vendors, Siemens Medical Solutions, GE Healthcare, Philips Healthcare, since ADC values obtained with these 3 vendors have been shown comparable each other [22] . Despite the small number of patients, application of these 3 vendors enabled us to demonstrate significant difference of ADC values between patients with fulminant type 1 diabetes and non-diabetic control subjects with simple imaging parameters. It is also a limitation that we could not make a comparison of ADC values between fulminant type 1 diabetes and other type 1 or type 2 diabetes in this retrospective study. A prospective study is required to confirm our present results.
In conclusion, the ADC values of pancreas were significantly lower in patients with fulminant type 1 diabetes than in controls. Low ADC values may reflect the severity of metabolic disorders in patients with fulminant type 1 diabetes. DWI may be an additional tool for making an efficient diagnosis of fulminant type 1 diabetes including patients difficult to diagnose. 
